SIGHT SCIENCES, INC. Increase (Decrease) in Other Noncurrent Liabilities
SIGHT SCIENCES, INC. (SGHT) reported Increase (Decrease) in Other Noncurrent Liabilities of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities · last filed 2026-03-04
- SIGHT SCIENCES, INC. increase (decrease) in other noncurrent liabilities for the quarter ending 2025-12-31 was $0.00.
- SIGHT SCIENCES, INC. increase (decrease) in other noncurrent liabilities for the quarter ending 2025-09-30 was $0.00.
- SIGHT SCIENCES, INC. increase (decrease) in other noncurrent liabilities for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- SIGHT SCIENCES, INC. increase (decrease) in other noncurrent liabilities for the quarter ending 2025-03-31 was $0.00.
- SIGHT SCIENCES, INC. increase (decrease) in other noncurrent liabilities for fiscal 2025 was $0.00.
- SIGHT SCIENCES, INC. increase (decrease) in other noncurrent liabilities for fiscal 2024 was -$1.56M, a 573.64% decline from fiscal 2023.
- SIGHT SCIENCES, INC. increase (decrease) in other noncurrent liabilities for fiscal 2023 was $330.00K, a 6.52% decline from fiscal 2022.
- SIGHT SCIENCES, INC. increase (decrease) in other noncurrent liabilities for fiscal 2022 was $353.00K, a 390.28% increase from fiscal 2021.
| Period end | Increase (Decrease) in Other Noncurrent Liabilities 3 month | Increase (Decrease) in Other Noncurrent Liabilities 6 month | Increase (Decrease) in Other Noncurrent Liabilities 9 month | Increase (Decrease) in Other Noncurrent Liabilities 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $0.00 derived: sum of 2 quarters · filed 2026-03-04 | $0.00 derived: sum of 3 quarters · filed 2026-03-04 | $0.00 10-K · filed 2026-03-04 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $0.00 derived: sum of 2 quarters · filed 2025-11-06 | $0.00 10-Q · filed 2025-11-06 | -$39.00K derived: sum of 4 quarters · filed 2026-03-04 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $0.00 10-Q · filed 2025-08-07 | -$39.00K derived: sum of 3 quarters · filed 2026-03-04 | -$235.00K derived: sum of 4 quarters · filed 2026-03-04 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-08 | -$39.00K derived: sum of 2 quarters · filed 2026-03-04 | -$235.00K derived: sum of 3 quarters · filed 2026-03-04 | -$122.00K derived: sum of 4 quarters · filed 2026-03-04 |
| 2024-12-31 | -$39.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | -$235.00K derived: sum of 2 quarters · filed 2026-03-04 | -$122.00K derived: sum of 3 quarters · filed 2026-03-04 | -$1.56M 10-K · filed 2026-03-04 |
| 2024-09-30 | -$196.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$83.00K derived: sum of 2 quarters · filed 2025-11-06 | -$1.52M 10-Q · filed 2025-11-06 | -$1.44M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $113.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$1.33M 10-Q · filed 2025-08-07 | -$1.24M derived: sum of 3 quarters · filed 2025-08-07 | -$1.16M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | -$1.44M 10-Q · filed 2025-05-08 | -$1.35M derived: sum of 2 quarters · filed 2025-05-08 | -$1.27M derived: sum of 3 quarters · filed 2025-05-08 | -$1.19M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $88.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | $172.00K derived: sum of 2 quarters · filed 2025-03-07 | $253.00K derived: sum of 3 quarters · filed 2025-03-07 | $330.00K 10-K · filed 2025-03-07 |
| 2023-09-30 | $84.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $165.00K derived: sum of 2 quarters · filed 2024-11-07 | $242.00K 10-Q · filed 2024-11-07 | $325.00K derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $81.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | $158.00K 10-Q · filed 2024-08-02 | $241.00K derived: sum of 3 quarters · filed 2024-08-02 | $335.00K derived: sum of 4 quarters · filed 2024-08-02 |
| 2023-03-31 | $77.00K 10-Q · filed 2024-05-06 | $160.00K derived: sum of 2 quarters · filed 2024-05-06 | $254.00K derived: sum of 3 quarters · filed 2024-05-06 | $344.00K derived: sum of 4 quarters · filed 2024-05-06 |
| 2022-12-31 | $83.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $177.00K derived: sum of 2 quarters · filed 2024-03-13 | $267.00K derived: sum of 3 quarters · filed 2024-03-13 | $353.00K 10-K · filed 2024-03-13 |
| 2022-09-30 | $94.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $184.00K derived: sum of 2 quarters · filed 2023-11-07 | $270.00K 10-Q · filed 2023-11-07 | $63.00K derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $90.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $176.00K 10-Q · filed 2023-08-07 | -$31.00K derived: sum of 3 quarters · filed 2023-08-07 | $62.00K derived: sum of 4 quarters · filed 2023-08-07 |
| 2022-03-31 | $86.00K 10-Q · filed 2023-05-08 | -$121.00K derived: sum of 2 quarters · filed 2023-05-08 | -$28.00K derived: sum of 3 quarters · filed 2023-05-08 | $67.00K derived: sum of 4 quarters · filed 2023-05-08 |
| 2021-12-31 | -$207.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | -$114.00K derived: sum of 2 quarters · filed 2023-03-16 | -$19.00K derived: sum of 3 quarters · filed 2023-03-16 | $72.00K 10-K · filed 2023-03-16 |
| 2021-09-30 | $93.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $188.00K derived: sum of 2 quarters · filed 2022-11-10 | $279.00K 10-Q · filed 2022-11-10 | $135.00K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $95.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $186.00K 10-Q · filed 2022-08-11 | $42.00K derived: sum of 3 quarters · filed 2022-08-11 | $344.00K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $91.00K 10-Q · filed 2022-05-10 | -$53.00K derived: sum of 2 quarters · filed 2022-05-10 | $249.00K derived: sum of 3 quarters · filed 2022-05-10 | |
| 2020-12-31 | -$144.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $158.00K derived: sum of 2 quarters · filed 2022-03-24 | $614.00K 10-K · filed 2022-03-24 | |
| 2020-09-30 | $302.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $758.00K 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | $456.00K 10-Q · filed 2021-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |